Huadong Medicine Co Ltd 2023 SR
The report highlights Huadong Medicine's 2023 ESG performance, focusing on its transformation into an innovation-driven pharmaceutical powerhouse. Key achievements include the domestic approval of Liraglutide injection for diabetes and obesity, and the advancement of a diverse R&D pipeline in oncology, endocrinology, and autoimmunity. The company emphasized environmental stewardship, investing RMB 73.15 million in protection initiatives and achieving "Zero Waste Factory" status for a subsidiary. Socially, it maintained 100% social insurance coverage for employees and donated RMB 27.37 million to charitable causes. Governance was bolstered through a robust ESG management framework and high ratings from agencies like Wind (A) and MSCI (BBB).
Company: Huadong Medicine Co Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 51
Huadong Medicine Co Ltd
ESG Report
The report highlights Huadong Medicine's 2023 ESG performance, focusing on its transformation into an innovation-driven pharmaceutical powerhouse. Key achievements include the domestic approval of Liraglutide injection for diabetes and obesity, and the advancement of a diverse R&D pipeline in oncology, endocrinology, and autoimmunity. The company emphasized environmental stewardship, investing RMB 73.15 million in protection initiatives and achieving "Zero Waste Factory" status for a subsidiary. Socially, it maintained 100% social insurance coverage for employees and donated RMB 27.37 million to charitable causes. Governance was bolstered through a robust ESG management framework and high ratings from agencies like Wind (A) and MSCI (BBB).
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees